{
    "nct_id": "NCT03292874",
    "official_title": "Evaluation of a Novel High-Resolution Diffusion-Weighted MRI Sequence",
    "inclusion_criteria": "* Age over 18 years\n* Patients diagnosed with clinically localized prostate cancer\n* Low or Low-intermediate Risk Prostate cancer1 defined as:\n* Pre-operative prostate specific antigen (PSA) â‰¤ 20.0 ng/ml\n* Clinical stage cT1 or cT2\n* Gleason score 3+3 or 3+4\n* Patients choosing AS or already on AS as primary management strategy\n* No previous treatment for prostate cancer with radiotherapy, chemotherapy, or hormonal therapy\n* No contraindications for gadolinium enhanced MRI\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 19 Years",
    "exclusion_criteria": "* No exclusion criteria",
    "miscellaneous_criteria": ""
}